WAT

Waters Corporation Common Stock (WAT)

Stock · NYSE · Industrials

$414.69as of 8/28/2026

AI Market Commentary

AI-generated

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

August 30, 2026

Piper Sandler Upgrades Waters to Overweight, Lifts Price Target. Piper Sandler upgraded Waters Corporation to Overweight, raising its price target to $480. The move was highlighted among several top upgrades of the day, with the analyst turning more positive on the stock. Separately, a retrospective noted how a $1,000 investment in Waters 20 years ago would have grown significantly. The stock trades well above its 52-week low of $278.49, with RSI near 60 indicating recent upward momentum.

Active signals

No technical signal is currently active for this symbol.

Support level
$372.57
Industry
Biotechnology: Laboratory Analytical Instruments

Fundamentals

Market cap
$36.79B
P/E (trailing)
P/E (forward)
EPS (trailing)
Dividend yield
Beta
Avg. volume

How Waters Corporation Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$3.17BCost of Revenue$1.29B (41%)SG&A$830.37M (26%)Other$738.13M (23%)R&D$195.71M (6%)Tax$112.25M (4%)WAT

Source: 10-K filed Feb 23, 2026 · via SEC EDGAR / Finnhub

Waters Corporation Common Stock Competitors

Chosen by industry and closest market cap.

  • WAT
    Waters Corporation Common Stock
    $414.69
    ▼ 1.56%
    Market cap $36.79BP/E
  • A
    Agilent Technologies Inc. Common Stock
    $153.84
    ▼ 2.44%
    Market cap $39.48BP/E 29.37
    $108.35$163.75
  • RVTY
    Revvity Inc. Common Stock
    $128.8
    ▼ 0.70%
    Market cap $12.85BP/E 55.10
    $81.22$129.8
  • TXG
    10x Genomics Inc. Class A Common Stock
    $61.55
    ▼ 5.10%
    Market cap $5.97BP/E
    $11.16$66.94
  • EYPT
    EyePoint Inc. Common Stock
    $4.47
    ▼ 3.46%
    Market cap $1.04BP/E
    $3.95$19.11
  • CTKB
    Cytek Biosciences Inc. Common Stock
    $4.69
    ▲ 1.41%
    Market cap $556.60MP/E
    $3.28$6.18
  • PACB
    Pacific Biosciences of California Inc. Common Stock
    $1.4
    ▼ 10.00%
    Market cap $441.05MP/E
    $1.07$2.73

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
1.8K
Disposed
5.3K

Institutional Ownership

March 31, 2026

Total shares held
87.44M
Total value held
$24.57B
Institutional holders
1158
Top holders this quarter
  • Unknown8.54M
  • Unknown6.38M
  • Unknown4.66M
  • Unknown4.63M
  • Unknown4.36M
  • Unknown3.21M
  • Unknown2.65M
  • Unknown2.17M
  • Unknown2.12M
  • Unknown1.64M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.